Elsie Oyoo

Investing Profile

Sweet spot: $1.5M Range: $100K–$5M

2Flo Ventures thesis

Vivacelle Bio Vivacelle Bio leverages phospholipid nanoparticles treating relative (nitric oxide induced) and absolute hypovolemia due to septic or hemorrhagic shock. Temprian Therapeutics A biotech company focused on developing a safe and effective treatment for the skin depigmentation disease, Vitiligo. Delphian Therapeutics Delphian Therapeutics is a pioneer in FDA-approved, cannabinoid-based pain relief for hard-to-treat musculoskeletal and neurological conditions. Pain is commonly undertreated in patients of color and is shown to exacerbate adverse health outcomes. ResQ Pharma ResQ Pharma

Sector and stage focus

  • Seed: LegalTech
  • Series A: LegalTech

Is Elsie Oyoo a fit for your round?

Upload your pitch deck and see whether Elsie Oyoo appears in your top 20 matches.

Find investors for your deck